Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1125258

registered interest
date	08/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ovarian Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the incidence of ovarian cancer; and if he will make a statement.
tabling member constituency	Tewkesbury
tabling member printed	Mr Laurence Robertson
uin	251890
answer	answer is ministerial correction date of answer 13/05/2019 answer text <p>Prevention is a key focus of the NHS Long Term Plan, which sets out plans to tackle risk factors for cancer such as obesity, alcohol consumption and smoking. This will have a significant impact on improving health, including for those who are at risk of developing ovarian cancer. Over the next 10 years the National Health Service will extend the use of molecular diagnostic testing and routine offering genomic testing to all patients with cancer for whom it would be of clinical benefit.</p><p>From 2019 we will start the roll-out of new Rapid Diagnostic Centres across the country to upgrade and bring together the latest diagnostic equipment and expertise, building on 10 models piloted with Cancer Research UK, which have focused on diagnosing cancers where patients often present with non-specific symptoms, often the case with ovarian cancer, and may go to their general practitioner many times before being sent for tests, such as blood and stomach cancers.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 13/05/2019 15:44:05 answering member 4455 label Biography information for Seema Kennedy
tabling member	253 label Biography information for Mr Laurence Robertson

1125259

registered interest
date	08/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ovarian Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to improve the treatment of ovarian cancer; and if he will make a statement.
tabling member constituency	Tewkesbury
tabling member printed	Mr Laurence Robertson
uin	251891
answer	answer is ministerial correction date of answer 13/05/2019 answer text <p>The NHS Cancer Programme is committed through the NHS Long Term Plan to improve access to treatments for all cancer patients and reduce health inequalities. Cancer Alliances are working with local sustainability and transformation partnerships and integrated care systems to reduce variation on patient outcomes and experience.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 13/05/2019 15:43:12 answering member 4455 label Biography information for Seema Kennedy
tabling member	253 label Biography information for Mr Laurence Robertson

994276

registered interest
date	24/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ovarian Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to (a) improve public awareness of ovarian cancer and its symptoms, (b) increase early diagnosis rates and (c) increase access to treatment in specialist centres in (i) Oxfordshire and (ii) England.
tabling member constituency	Oxford West and Abingdon
tabling member printed	Layla Moran
uin	183497
answer	answer is ministerial correction date of answer 29/10/2018 answer text <p>Public Health England has run a number of “Be Clear on Cancer” (BCOC) campaigns to help improve earlier diagnosis. In 2014, BCOC conducted a regional ovarian cancer campaign and in 2017, a pilot which focussed on a range of abdominal symptoms, such as diarrhoea, bloating and discomfort that can be indicative of a number of cancers, including ovarian cancer. Decisions on which cancers the BCOC campaigns should focus on are informed by a steering group and the outcomes of the regional and pilot campaigns will be considered for 2019/20.</p><p> </p><p>Nationally, NHS England is testing innovative ways of diagnosing cancer earlier, with sites piloting multi-disciplinary diagnostic centres for patients with vague or non-specific symptoms. The pilots are taking place in London, Greater Manchester, Leeds, Bristol, Oxfordshire and Airedale, Wharfedale and Craven (Yorkshire). The Prime Minister’s October 2018 announcement pledged to roll out these rapid diagnostic centres across the country to offer patients a range of tests in the same day with rapid access to results. The centres will help make a huge improvement in early diagnosis.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 29/10/2018 17:54:43 answering member 4067 label Biography information for Steve Brine
tabling member	4656 label Biography information for Layla Moran

747622

registered interest
date	03/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Ovarian Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when he plans to publish the two research studies into ovarian cancer awareness which the previous Government indicated it planned to publish in the summer of 2017.
tabling member constituency	Wellingborough
tabling member printed	Mr Peter Bone
uin	2424
answer	answer is ministerial correction date of answer 06/07/2017 answer text <p>Public Health England (PHE) has published one full evaluation report on the pilot campaign and one interim report on the regional campaign for the Be Clear on Cancer ovarian cancer campaign.</p><p> </p><p>The full evaluation of the local ovarian cancer pilot campaign which ran from 14 January – 17 March 2013 it can be accessed here:</p><p><a href="https://www.gov.uk/government/publications/ovarian-cancer-awareness-campaign-local-pilots-evaluation-report" target="_blank">https://www.gov.uk/government/publications/ovarian-cancer-awareness-campaign-local-pilots-evaluation-report</a></p><p> </p><p>The interim evaluation report on the regional ovarian cancer awareness campaign, which ran from 10 February- 16 March 2014 in the North West of England it can be accessed here:</p><p><a href="http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/be_clear_on_cancer/" target="_blank">http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/be_clear_on_cancer/</a></p><p> </p><p>PHE is planning to produce a full and final evaluation report for the Be Clear on Cancer ovarian cancer awareness regional campaign by April 2018.</p><p> </p><p>The Department’s Policy Research Unit on Cancer Awareness Screening and Early Diagnosis has undertaken a qualitative research study in which members of the public were given access to available leaflets on ovarian cancer awareness and then participated in six focus groups and interviews on their acceptability and how they would be received and understood if included within the clear screening results letter from the breast or cervical screening programme.</p><p> </p><p>This study is now complete and has been presented at the recent Cancer Research UK Early Diagnosis conference. The work is currently being written up for submission to a peer-reviewed medical journal. The Health Research Authority approval for a further qualitative research study with professionals has now been granted, and the work is in progress.</p><p> </p><p>A second project is a synthesis of published incidence, mortality, stage distribution and stage-specific survival rates for ovarian cancer by age. The aim of this project was to identify which age group would be most likely to benefit from such an intervention, in terms of risk of ovarian cancer, and room for improvement in stage at diagnosis. This study is now also complete, fully written up, and has been submitted to a journal for publication. The journal’s response is awaited.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/07/2017 14:52:45 answering member 4067 label Biography information for Steve Brine
tabling member	1581 label Biography information for Mr Peter Bone

705621

registered interest
date	27/02/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Ovarian Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when NHS England plans to publish its service specification on ovarian cancer.
tabling member constituency	Wellingborough
tabling member printed	Mr Peter Bone
uin	65673
answer	answer is ministerial correction date of answer 02/03/2017 answer text <p>In order for NHS England to formally consider a new or revised service specification, a number of associated reports and processes need to be completed. The Complex Gynaecological Services Clinical Reference Group (CRG) did start the process of developing a new service specification for ovarian cancer, however, this did not progress through the process. This was due to technical difficulties encountered during the Impact Assessment stage and included issues in identifying activity and the associated financial impact.</p><p> </p><p>In the subsequent period, CRGs have been restructured and the responsibility for this clinical area now resides with the Specialised Cancer Surgery CRG, within the National Cancer Programme of Care. In addition, NHS England has also published a revised process for service specification development (titled: ‘Methods’), which can be found at:</p><p><a href="https://www.england.nhs.uk/commissioning/spec-services/key-docs/" target="_blank">https://www.england.nhs.uk/commissioning/spec-services/key-docs/</a></p><p> </p><p>The Methods sets out the process for completing service specification work and, in accordance with this process, the Specialised Cancer Surgery CRG has been asked to consider progressing this work. The CRG Chair is due to discuss the matter with a representative of the Gynaecology CRG later this week and, following this, it is expected that the first step of the process will be completed by the middle of March 2017.</p> answering member constituency Warrington South answering member printed David Mowat question first answered 02/03/2017 11:10:35 answering member 4080 label Biography information for David Mowat
tabling member	1581 label Biography information for Mr Peter Bone

178159

registered interest
date	05/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Ovarian Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effect of the Be Clear on Cancer regional pilot in ovarian cancer on (a) survival rates, (b) early diagnosis and (c) general awareness of ovarian cancer.
tabling member constituency	Pudsey
tabling member printed	Stuart Andrew
uin	223596
answer	answer is ministerial correction date of answer 10/02/2015 answer text <p>For each Be Clear on Cancer campaign there is a comprehensive evaluation process. Data is collected on a number of metrics to reflect the possible campaign impact on key elements of the patient pathway. Metrics evaluated include survival rates, indicators for earlier diagnosis and general awareness of ovarian cancer symptoms.</p><p> </p><p> </p><p> </p><p>For the regional ovarian pilot in the North West, we have so far been able to look at the following metrics:</p><p> </p><p>- cancer awareness levels;</p><p> </p><p>- urgent general practitioner (GP) (two week wait) referrals for suspected gynaecological cancers;</p><p> </p><p>- ovarian cancers diagnosed following a two week wait referral;</p><p> </p><p>- all ovarian cancers diagnosed and recorded in the cancer waiting times database;</p><p> </p><p>- conversion rate (percentage of two week wait referrals resulting in a cancer diagnosis); and</p><p> </p><p>- detection rate (percentage of Cancer Waiting Times (CWT) recorded cancers resulting from a two week wait referral).</p><p> </p><p> </p><p> </p><p>Some of the information required to fully evaluate campaigns takes longer to collate and analyse but gradually over time, when combined together, the metrics we analyse build up a detailed picture of potential campaign effects. This will include analysis of the following data:</p><p> </p><p>- GP attendances;</p><p> </p><p>- diagnostic tests, including CA125;</p><p> </p><p>- numbers of cancers recorded by the National Cancer Registration Service;</p><p> </p><p>- stage at diagnosis; and</p><p> </p><p>- one year survival.</p><p> </p><p><strong> </strong></p><p> </p><p>The National Cancer Intelligence Network (part of Public Health England) have confirmed that they will publish a full and final evaluation report for the regional ovarian cancer pilot campaign as soon as possible, when analysis of all metrics is complete. However, in advance of a final evaluation report, they aim to publish an interim report containing the cancer awareness levels and the results from the analysis of CWT data before the end of February 2015, at which time we will share these results with the ovarian cancer expert group and ovarian cancer charities.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 10/02/2015 16:09:39 answering member 3918 label Biography information for Jane Ellison
tabling member	4032 label Biography information for Stuart Andrew

177186

registered interest
date	02/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Ovarian Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will meet bodies representing cancer sufferers to discuss the evaluation of the Be Clear on Cancer regional pilot for ovarian cancer.
tabling member constituency	Pudsey
tabling member printed	Stuart Andrew
uin	222849
answer	answer is ministerial correction date of answer 05/02/2015 answer text <p>For each Be Clear on Cancer campaign there is a comprehensive evaluation process. Data is collected on a number of metrics to reflect the possible campaign impact on key elements of the patient pathway.</p><p> </p><p> </p><p> </p><p>The National Cancer Intelligence Network (part of Public Health England) have confirmed that they will publish a full and final evaluation report for the regional ovarian cancer pilot campaign as soon as possible, when analysis of all metrics is complete. However, in advance of a final evaluation report, they aim to publish an interim report containing the cancer awareness levels and the results from the analysis of Cancer Waiting Times data before the end of February 2015, at which time we will arrange a meeting with Public Health England and ovarian cancer charities to discuss these results.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 05/02/2015 17:49:22 answering member 3918 label Biography information for Jane Ellison
tabling member	4032 label Biography information for Stuart Andrew

155937

registered interest
date	17/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Ovarian Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effectiveness of the implementation of the National Institute for Health and Care Excellence's most recent guidelines for genetic testing for ovarian cancer.
tabling member constituency	South Down
tabling member printed	Ms Margaret Ritchie
uin	214812
answer	answer is ministerial correction date of answer 20/11/2014 answer text <p>The National Institute for Health and Care Excellence’s clinical guideline on familial breast cancer, published in June 2013, recommends that women with breast or ovarian cancer should be offered genetic testing if their combined BRCA1 and BRCA2 mutation carrier possibility is 10% or more.</p><p> </p><p> </p><p> </p><p>NHS England is considering moving to a lower threshold as part of the annual prioritisation process for funding in 2015-16.</p><p> </p><p><strong> </strong></p><p> </p><p>We intend to raise the matter of genetic testing for ovarian cancer patients with the Health Ministers of Scotland, Wales, and Northern Ireland in our next regular meeting with them.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 214783 question first answered 20/11/2014 16:50:39 answering member 3918 label Biography information for Jane Ellison
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

100023

registered interest
date	15/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Ovarian Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to increase early identification of ovarian cancer.
tabling member constituency	Washington and Sunderland West
tabling member printed	Mrs Sharon Hodgson
uin	905561
answer	answer is ministerial correction date of answer 21/10/2014 answer text <p>We are investing £450 million in earlier diagnosis of cancer, including improving direct general practitioner access to non-obstetric ultrasound to support earlier diagnosis of ovarian cancer.</p><p> </p><p> </p><p> </p><p>Public Health England ran a regional Be Clear on Cancer campaign early in 2014 to raise awareness of the symptoms of ovarian cancer. The findings of the pilot will be evaluated in 2015, and this evidence would inform any decision to move from a regional to national campaign.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 21/10/2014 15:46:38 answering member 3918 label Biography information for Jane Ellison
tabling member	1521 label Biography information for Mrs Sharon Hodgson